在口腔状细胞癌中,Caveolin-1 通过铁灭酶调节 Cisplatin 的敏感性
Weilin Zhang1,2, Xinyi Yang1, Wei Lin1
1School of Stomatology, Guizhou Medical University, Guiyang, Guizhou, China.
概括
在口腔状细胞癌 (OSCC) 中高表达的Caveolin-1 (CAV1) 促进瘤的进展,并通过抑制铁. 这一发现为改善OSCC治疗提供了潜在的治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 西斯普拉丁化疗是口腔状细胞癌 (OSCC) 的标准治疗方法.
- 药物耐药性和对西斯丁的敏感性降低限制了其在OSCC的治疗疗效.
- 凯沃林-1 (CAV1) 涉及瘤化疗耐药性和铁亡调节.
研究的目的:
- 调查CAV1在调节OSCC对西斯素敏感性的作用.
- 为了确定CAV1是否通过铁亡途径影响OSCC的进展.
主要方法:
- 在OSCC中对CAV1表达和预后的生物信息分析.
- 免疫组织化学验证CAV1的表达.
- 试验室内实验包括CAV1沉默,细胞迁移/入侵测定,CCK8测定和西斑测定,以评估铁亡标志物.
主要成果:
- 在OSCC中,CAV1的表达很高,与预后不佳相关.
- 在OSCC中,CAV1的表达与药物代谢和免疫细胞透有关.
- CAV1 抑制铁和思丁敏感性,增强OSCC细胞迁移和入侵.
结论:
- CAV1促进了OSCC的进展.
- 在OSCC中,CAV1通过调节细胞铁亡来调节思普拉丁的敏感性.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


